What are side effects of AMPYRA?
Side Effects of Ampyra
- Urinary tract infections.
- Trouble sleeping.
- Dizziness.
- Headache.
- Nausea.
- Weakness.
- Back pain.
- Balance problems.
What does the drug AMPYRA do?
Dalfampridine is used to improve walking in people with multiple sclerosis (MS). It is a potassium channel blocker. It is thought to work by improving nerve conduction.
Does Dalfampridine help nerve pain?
In laboratory studies, dalfampridine has been found to improve impulse conduction in demyelinated nerve fibers and to increase synaptic transmitter release at nerve endings.
What is Ampyra made of?
What are the ingredients in AMPYRA? Inactive ingredients: colloidal silicon dioxide, hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, and titanium dioxide.
What is the cost of Ampyra?
The cost for Ampyra oral tablet, extended release 10 mg is around $3,364 for a supply of 60 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
What is ampyra made of?
Does ampyra work everyone?
AMPYRA does not work for everyone, and people experience different levels of response to the medication. It is important to take AMPYRA as prescribed by your doctor.
What is the medicine Dalfampridine used for?
Dalfampridine is used to improve walking in people who have multiple sclerosis (MS; a disease in which the nerves do not function properly and may cause weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control).
What is the brand name of Dalfampridine?
AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg, is the first and only brand prescription medicine indicated to help improve walking in adults with multiple sclerosis (MS).
Where is ampyra manufactured?
Please see Patient Medication Guide for additional safety information. AMPYRA is a registered trademark of Acorda Therapeutics, Inc. AMPYRA is marketed by Acorda Therapeutics, Inc. and manufactured under license from Alkermes Pharma Limited (APIL), Ireland.